Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
J Thorac Oncol. 2009 Oct;4(10):1293-300. doi: 10.1097/JTO.0b013e3181b7ef95.
Over the past decade, gradual progress has been made in improving the outcomes of patients with lung cancer. This review summarizes the findings from selected studies presented at the recently concluded 45th annual meeting of the American Society of Clinical Oncology. This report will focus only on findings that are of immediate relevance to clinical practice. The topics discussed here range from the long-term safety of adjuvant chemotherapy and a new systemic chemotherapy regimen for locally advanced non-small cell lung cancer to the emerging issue of maintenance chemotherapy and the use of biomarkers in the treatment of patients with metastatic non-small cell lung cancer.
在过去的十年中，在改善肺癌患者的治疗效果方面取得了逐步进展。本综述总结了最近举行的第 45 届美国临床肿瘤学会年会上展示的部分研究结果。本报告仅关注与临床实践直接相关的发现。这里讨论的主题范围从辅助化疗的长期安全性和局部晚期非小细胞肺癌的新的系统化疗方案到维持化疗的新出现问题以及生物标志物在转移性非小细胞肺癌患者治疗中的应用。
